Sartorius to Host 2023 Sartorius Summit Event
16 Mar 2023
Financial Statement
Event will feature industry leaders, cutting-edge technology in cell line development CAMBRIDGE-March 16, 2023- Sartorius, a leading international partner of life science research and the biopharmaceutical industry, will host the Sartorius Summit: Shaping CLD Solutions Through Expert Insight event today. The event will feature leading industry experts who will lead robust panel discussions on accelerating and optimizing the cell line development (CLD) process. The Sartorius Summit event will introduce participants to the latest developments in CLD technology and provide solutions and risk management strategies to overcome challenges throughout every step of the CLD workflow. Participants will also gain a deeper understanding of how a single vendor approach can minimize risks and optimize outcomes for life science companies looking to produce a safe, reliable product. “Our goal at Sartorius is to accelerate and simplify therapeutic development for our biomanufacturing partners worldwide. We are supporting the optimization of cell line development for commercial scale by focusing on increasing scalable productivity, reducing timelines, and minimizing risk,” said Hugo de Wit, Head of Business Area Cell Culture Technologies at Sartorius. "Through our cell line and media development technologies and in-house services, our customers have successfully applied for more than 200 molecules of different types which are either in clinic or have obtained market approval.” “Last year, Sartorius closed on a deal to acquire a majority stake in Automated Lab Solutions (ALS) which added the CellCelector Flex platform to our portfolio of highthroughput and automated bioanalytical instruments,” said Fiona Coats, Ph.D., Head of Marketing, Lab Products & Services, Sartorius. “The CellCelector single cell and colony picking platform is used for high-throughput single cell cloning, allowing faster and simpler generation of clonal production cell lines. This complementary technology delivers on our promise of “Simplifying Progress” and nicely rounds out our end-to-end solutions for cell line development workflows.” The Sartorius Summit event will take place in the heart of Kendall Square at Mass Bio’s headquarters at 700 Technology Square, Floor 5, in Cambridge, MA from 10am-5pm. Parking is available close to the venue. About Sartorius: The Sartorius Group is a leading international partner of life sciences research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the group’s Lab Products & Services division concentrates on serving the needs of laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies and those of academic research institutes. The Bioprocess Solutions division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The company is growing at double-digit rates on average per year and regularly expands its portfolio through the acquisition of complementary technologies. In fiscal 2022, the company generated sales revenues of around 4.2 billion euros according to preliminary figures. At the end of 2022, around 16,000 employees were working for customers around the globe at the group’s 60 or so production and sales sites.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.